Enables querying China-to-Western biotech licensing deals, NMPA drug approvals and policy updates, and CSRC securities penalties, all extracted from public SEC, HKEX, and government filings without an API key.
Provides keyless access to HKEX and CNINFO exchange disclosure feeds, enabling search and retrieval of Chinese biotech licensing deals and Hong Kong/STAR IPO financing filings.
Enables read-only research into parsed SEC events keyed by CIK and CUSIP, including 8-K items, Form 144, Form D, FTD series, XBRL facts, Form 4 insider trades, and 13F filings.